Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2019 Filed Feb 2, 2019 00:58 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 40,000 | $5.56 | $222,400.00 |
DisclosureSEC source: 0000939767-19-000016 · wf-form4_154906911161318.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 01:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 400 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0000939767-19-000014 · wf-form4_154786056275509.xml · derivative · entry 7 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,000 Underlying: Common Stock · 400 shares Expires 2019-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 402,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 01:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 39,600 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0000939767-19-000014 · wf-form4_154786056275509.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,400 Underlying: Common Stock · 39,600 shares Expires 2019-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 402,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 01:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 400 | $23.92 | $9,568.00 |
DisclosureSEC source: 0000939767-19-000014 · wf-form4_154786056275509.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2018. F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.90 to $23.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 01:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 39,600 | $23.28 | $921,888.00 |
DisclosureSEC source: 0000939767-19-000014 · wf-form4_154786056275509.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,400 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.90 to $23.89. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 01:16 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 40,000 | $5.56 | $222,400.00 |
DisclosureSEC source: 0000939767-19-000014 · wf-form4_154786056275509.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 10, 2019 Filed Jan 12, 2019 00:56 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-19-000012 · wf-form4_154725456101089.xml · derivative · entry 6 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,375 Underlying: Common Stock · 2,000 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018. Read SEC document |
| January 10, 2019 Filed Jan 12, 2019 00:56 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 1,000 | $23.54 | $23,540.00 |
DisclosureSEC source: 0000939767-19-000012 · wf-form4_154725456101089.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. Read SEC document |
| January 10, 2019 Filed Jan 12, 2019 00:56 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 2,000 | $24.00 | $48,000.00 |
DisclosureSEC source: 0000939767-19-000012 · wf-form4_154725456101089.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. Read SEC document |
| January 10, 2019 Filed Jan 12, 2019 00:56 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 2,000 | $1.76 | $3,520.00 |
DisclosureSEC source: 0000939767-19-000012 · wf-form4_154725456101089.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 1,560 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · derivative · entry 14 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,680 Underlying: Common Stock · 1,560 shares Expires 2020-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 7,800 shares of Exelixis, Inc. common stock, became fully exercisable on September 30, 2017. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 1,560 | $23.50 | $36,660.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 8 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. Read SEC document |
| January 09, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 1,560 | $5.82 | $9,079.20 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 7 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · derivative · entry 13 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,375 Underlying: Common Stock · 2,000 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 2,000 | $23.00 | $46,000.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 6 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 2,000 | $1.76 | $3,520.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 5 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 00:47 UTC |
Garber Alan MDirector
|
Exercise / conversionOption (right to buy) · Derivative | 11,250 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000939767-19-000009 · wf-form4_154708125252237.xml · derivative · entry 3 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2010. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 00:47 UTC |
Garber Alan MDirector
|
SaleCommon Stock | 11,250 | $23.00 | $258,750.00 |
DisclosureSEC source: 0000939767-19-000009 · wf-form4_154708125252237.xml · nonDerivative · entry 2 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,329 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2018. Read SEC document |
| January 08, 2019 Filed Jan 10, 2019 00:47 UTC |
Garber Alan MDirector
|
Exercise / conversionCommon Stock | 11,250 | $4.16 | $46,800.00 |
DisclosureSEC source: 0000939767-19-000009 · wf-form4_154708125252237.xml · nonDerivative · entry 1 Garber Alan M · CIK 0001312907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 4,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · derivative · entry 12 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,375 Underlying: Common Stock · 4,000 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 1,560 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · derivative · entry 11 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,240 Underlying: Common Stock · 1,560 shares Expires 2020-09-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 7,800 shares of Exelixis, Inc. common stock, became fully exercisable on September 30, 2017. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 4,000 | $21.52 | $86,080.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 4 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.03 to $22.00. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 4,000 | $1.76 | $7,040.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 3 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 1,560 | $21.50 | $33,540.00 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:49 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 1,560 | $5.82 | $9,079.20 |
DisclosureSEC source: 0000939767-19-000010 · wf-form4_154708134136115.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 30,383 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · derivative · entry 12 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,000 Underlying: Common Stock · 30,383 shares Expires 2019-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 402,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 30,383 | $20.14 | $611,913.62 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · nonDerivative · entry 8 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2018. F5 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.38. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,383 | $5.56 | $168,929.48 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · nonDerivative · entry 7 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 3,571 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · derivative · entry 11 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,383 Underlying: Common Stock · 3,571 shares Expires 2019-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 402,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 3,571 | $20.00 | $71,420.00 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · nonDerivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2018. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,571 | $5.56 | $19,854.76 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:18 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 96 | $20.00 | $1,920.00 |
DisclosureSEC source: 0000939767-19-000004 · wf-form4_154665106994303.xml · nonDerivative · entry 4 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,031 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:15 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 8,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-19-000003 · wf-form4_154665088628836.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,375 Underlying: Common Stock · 8,000 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:15 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
SaleCommon Stock | 8,000 | $19.95 | $159,600.00 |
DisclosureSEC source: 0000939767-19-000003 · wf-form4_154665088628836.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,011 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 23, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.93 to $20.00. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 01:15 UTC |
Haley Patrick J.Sr. Vice President, Commercial
|
Exercise / conversionCommon Stock | 8,000 | $1.76 | $14,080.00 |
DisclosureSEC source: 0000939767-19-000003 · wf-form4_154665088628836.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · Sr. Vice President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,234 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock · Derivative | 6,046 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · derivative · entry 10 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,954 Underlying: Common Stock · 6,046 shares Expires 2019-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 402,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
SaleCommon Stock | 6,046 | $20.00 | $120,920.00 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F4 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2018. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 01:50 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,046 | $5.56 | $33,615.76 |
DisclosureSEC source: 0000939767-19-000006 · wf-form4_154665301832587.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 01:18 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 39,904 | $19.64 | $783,714.56 |
DisclosureSEC source: 0000939767-19-000004 · wf-form4_154665106994303.xml · nonDerivative · entry 3 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,403,127 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.18 to $20.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| December 15, 2018 Filed Jan 5, 2019 01:18 UTC |
SCANGOS GEORGE ADirector
|
GiftCommon Stock | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-19-000004 · wf-form4_154665106994303.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,443,031 Read SEC document |
| December 15, 2018 Filed Jan 5, 2019 01:18 UTC |
SCANGOS GEORGE ADirector
|
GiftCommon Stock | 4,650 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-19-000004 · wf-form4_154665106994303.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452,331 Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 01:03 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 40,000 | $21.16 | $846,400.00 |
DisclosureSEC source: 0000939767-18-000246 · wf-form4_154388540385711.xml · nonDerivative · entry 3 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,456,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.76 to $21.57. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 01:00 UTC |
Schwab GiselaPres, Prod Dev & Med Aff & CMO
|
Exercise / conversionOption (right to buy) · Derivative | 13,499 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0000939767-18-000244 · wf-form4_154388521379385.xml · derivative · entry 4 Schwab Gisela · CIK 0001213140 · Pres, Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,499 shares Expires 2018-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 01:00 UTC |
Schwab GiselaPres, Prod Dev & Med Aff & CMO
|
SaleCommon Stock | 13,499 | $21.02 | $283,748.98 |
DisclosureSEC source: 0000939767-18-000244 · wf-form4_154388521379385.xml · nonDerivative · entry 2 Schwab Gisela · CIK 0001213140 · Pres, Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,513 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.82 to $21.27. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| December 03, 2018 Filed Dec 4, 2018 01:00 UTC |
Schwab GiselaPres, Prod Dev & Med Aff & CMO
|
Exercise / conversionCommon Stock | 13,499 | $5.04 | $68,034.96 |
DisclosureSEC source: 0000939767-18-000244 · wf-form4_154388521379385.xml · nonDerivative · entry 1 Schwab Gisela · CIK 0001213140 · Pres, Prod Dev & Med Aff & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 30, 2018 Filed Dec 1, 2018 01:02 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 1,943 | $19.91 | $38,685.13 |
DisclosureSEC source: 0000939767-18-000242 · wf-form4_154362610864788.xml · nonDerivative · entry 3 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,820 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.91 to $19.92. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| November 30, 2018 Filed Dec 1, 2018 01:00 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 8,791 | $19.70 | $173,182.70 |
DisclosureSEC source: 0000939767-18-000241 · wf-form4_154362602423767.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,950 F1 · balance_after: Includes 56,875 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 01:03 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 8,500 | $20.00 | $170,000.00 |
DisclosureSEC source: 0000939767-18-000246 · wf-form4_154388540385711.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,496,981 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.01. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| November 29, 2018 Filed Dec 1, 2018 01:02 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 1,116 | $19.51 | $21,773.16 |
DisclosureSEC source: 0000939767-18-000242 · wf-form4_154362610864788.xml · nonDerivative · entry 2 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,763 Read SEC document |
| November 29, 2018 Filed Dec 4, 2018 01:03 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 6,500 | $20.00 | $130,000.00 |
DisclosureSEC source: 0000939767-18-000246 · wf-form4_154388540385711.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,481 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018. F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.03. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.